BioNexus Gene Lab Corp
Research BioNexus Gene Lab Corp (BGLC) on Bullrun: market cap USD 3.75M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBGLC
- ExchangeNASDAQ
- CountryMalaysia
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyUSD
- Market capUSD 3.75M
- Financial periodQ1 2026
- RevenueUSD 5.31M
- Net income-USD 543.58K
- Free cash flow-USD 148.00K
- Gross margin14.0%
Valuation Snapshot
latest market cap is USD 3.75M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 7.42M | -USD 2.98M | -USD 1.88M | 14.6% | -2.7 | USD 2.49M | USD 176.05K | USD 8.61M |
| FY2024 | USD 9.51M | -USD 1.60M | -USD 2.32M | 13.6% | -0.09 | USD 2.89M | USD 210.56K | USD 8.32M |
| FY2023 | USD 9.77M | -USD 2.63M | -USD 1.97M | 13.6% | -0.17 | USD 4.52M | USD 133.40K | USD 9.66M |
| FY2022 | USD 10.93M | -USD 355.97K | USD 551.82K | 11.5% | n/a | USD 2.12M | n/a | USD 6.67M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 3.75M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.55M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.03M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 9.43M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 165.04M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 364.69M | 5112.0 | n/a | n/a |
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is BioNexus Gene Lab Corp's market cap?
BioNexus Gene Lab Corp's market capitalization is USD 3.75M.
What does BioNexus Gene Lab Corp do?
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.